Similar findings of proportionally reduced total, CD4 T and CD8 naive T cells have been reported in cohorts of stage IV melanoma,14 and reduced absolute counts of total, CD4 T and CD8 T cells in non‐small cell lung cancer (NSCLC).13 The gene discussed is CD8A; the disease is melanoma.